251 related articles for article (PubMed ID: 33402820)
1. Risk of Pneumonia Associated with Inhaled Corticosteroid in Patients with Chronic Obstructive Pulmonary Disease: A Korean Population-Based Study.
Lee JH; Park YH; Kang DR; Lee SJ; Lee MK; Kim SH; Yong SJ; Lee WY
Int J Chron Obstruct Pulmon Dis; 2020; 15():3397-3406. PubMed ID: 33402820
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Risk of Pneumonia Caused by Fluticasone Propionate versus Budesonide in Chronic Obstructive Pulmonary Disease: A Nationwide Retrospective Cohort Study.
Choi JH; Jeong KB; Park YH; Yu I; Lee SJ; Lee MK; Kim SH; Lee WY; Yong SJ; Lee JH
Int J Chron Obstruct Pulmon Dis; 2021; 16():3229-3237. PubMed ID: 34858023
[TBL] [Abstract][Full Text] [Related]
3. Effects of inhaled corticosteroids /long-acting agonists in a single inhaler versus inhaled corticosteroids alone on all-cause mortality, pneumonia, and fracture in chronic obstructive pulmonary disease: A nationwide cohort study 2002-2013.
Cho KH; Kim YS; Linton JA; Nam CM; Choi Y; Park EC
Respir Med; 2017 Sep; 130():75-84. PubMed ID: 29206637
[TBL] [Abstract][Full Text] [Related]
4. Concomitant inhaled corticosteroid use and the risk of pneumonia in COPD: a matched-subgroup post hoc analysis of the UPLIFT® trial.
Tashkin DP; Miravitlles M; Celli BR; Metzdorf N; Mueller A; Halpin DMG; Anzueto A
Respir Res; 2018 Oct; 19(1):196. PubMed ID: 30290801
[TBL] [Abstract][Full Text] [Related]
5. Inhaled corticosteroid use in patients with chronic obstructive pulmonary disease and the risk of pneumonia: a retrospective claims data analysis.
Yawn BP; Li Y; Tian H; Zhang J; Arcona S; Kahler KH
Int J Chron Obstruct Pulmon Dis; 2013; 8():295-304. PubMed ID: 23836970
[TBL] [Abstract][Full Text] [Related]
6. The association between inhaled corticosteroid and pneumonia in COPD patients: the improvement of patients' life quality with COPD in Taiwan (IMPACT) study.
Wang CY; Lai CC; Yang WC; Lin CC; Chen L; Wang HC; Yu CJ
Int J Chron Obstruct Pulmon Dis; 2016; 11():2775-2783. PubMed ID: 27877031
[TBL] [Abstract][Full Text] [Related]
7. Intraclass Difference in Pneumonia Risk with Fluticasone and Budesonide in COPD: A Systematic Review of Evidence from Direct-Comparison Studies.
Lodise TP; Li J; Gandhi HN; O'Brien G; Sethi S
Int J Chron Obstruct Pulmon Dis; 2020; 15():2889-2900. PubMed ID: 33204085
[TBL] [Abstract][Full Text] [Related]
8. Comparative Safety and Effectiveness of Inhaled Corticosteroid and Long-Acting β
Chang TY; Chien JY; Wu CH; Dong YH; Lin FJ
Chest; 2020 May; 157(5):1117-1129. PubMed ID: 31887282
[TBL] [Abstract][Full Text] [Related]
9. Post-inhaled corticosteroid pulmonary tuberculosis and pneumonia increases lung cancer in patients with COPD.
Wu MF; Jian ZH; Huang JY; Jan CF; Nfor ON; Jhang KM; Ku WY; Ho CC; Lung CC; Pan HH; Wu MC; Liaw YP
BMC Cancer; 2016 Oct; 16(1):778. PubMed ID: 27724847
[TBL] [Abstract][Full Text] [Related]
10. Change in inhaled corticosteroid treatment and COPD exacerbations: an analysis of real-world data from the KOLD/KOCOSS cohorts.
Lee SH; Lee JH; Yoon HI; Park HY; Kim TH; Yoo KH; Oh YM; Jung KS; Lee SD; Lee SW
Respir Res; 2019 Mar; 20(1):62. PubMed ID: 30922302
[TBL] [Abstract][Full Text] [Related]
11. Risk of pneumonia with inhaled corticosteroid versus long-acting bronchodilator regimens in chronic obstructive pulmonary disease: a new-user cohort study.
DiSantostefano RL; Sampson T; Le HV; Hinds D; Davis KJ; Bakerly ND
PLoS One; 2014; 9(5):e97149. PubMed ID: 24878543
[TBL] [Abstract][Full Text] [Related]
12. Single-Inhaler Triple versus Dual Bronchodilator Therapy in COPD: Real-World Comparative Effectiveness and Safety.
Suissa S; Dell'Aniello S; Ernst P
Int J Chron Obstruct Pulmon Dis; 2022; 17():1975-1986. PubMed ID: 36065315
[TBL] [Abstract][Full Text] [Related]
13. Risk of pneumonia in obstructive lung disease: A real-life study comparing extra-fine and fine-particle inhaled corticosteroids.
Sonnappa S; Martin R; Israel E; Postma D; van Aalderen W; Burden A; Usmani OS; Price DB;
PLoS One; 2017; 12(6):e0178112. PubMed ID: 28617814
[TBL] [Abstract][Full Text] [Related]
14. Inhaled corticosteroids in COPD and the risk of lung cancer.
Lee YM; Kim SJ; Lee JH; Ha E
Int J Cancer; 2018 Nov; 143(9):2311-2318. PubMed ID: 29943812
[TBL] [Abstract][Full Text] [Related]
15. High versus Medium Dose of Inhaled Corticosteroid in Chronic Obstructive Lung Disease: A Systematic Review and Meta-Analysis.
Archontakis Barakakis P; Tran T; You JY; Hernandez Romero GJ; Gidwani V; Martinez FJ; Fortis S
Int J Chron Obstruct Pulmon Dis; 2023; 18():469-482. PubMed ID: 37056683
[TBL] [Abstract][Full Text] [Related]
16. Inhaled corticosteroids have a protective effect against lung cancer in female patients with chronic obstructive pulmonary disease: a nationwide population-based cohort study.
Liu SF; Kuo HC; Lin MC; Ho SC; Tu ML; Chen YM; Chen YC; Fang WF; Wang CC; Liu GH
Oncotarget; 2017 May; 8(18):29711-29721. PubMed ID: 28412726
[TBL] [Abstract][Full Text] [Related]
17. Inhaled corticosteroids and risk of pneumonia in patients with chronic obstructive pulmonary disease: A meta-analysis of randomized controlled trials.
Yang M; Du Y; Chen H; Jiang D; Xu Z
Int Immunopharmacol; 2019 Dec; 77():105950. PubMed ID: 31629940
[TBL] [Abstract][Full Text] [Related]
18. Inhaled Corticosteroid Treatment Regimens and Health Outcomes in a UK COPD Population Study.
Bloom CI; Douglas I; Usmani OS; Quint JK
Int J Chron Obstruct Pulmon Dis; 2020; 15():701-710. PubMed ID: 32308379
[TBL] [Abstract][Full Text] [Related]
19. Inhaled Corticosteroid-Related Tuberculosis in the Real World Among Patients with Asthma and COPD: A 10-Year Nationwide Population-Based Study.
Lee CM; Heo J; Han SS; Moon KW; Lee SH; Kim YJ; Lee SJ; Kwon JW
J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1197-1206.e3. PubMed ID: 30339858
[TBL] [Abstract][Full Text] [Related]
20. Inhaled Corticosteroid use and the Risk of Pneumonia and COPD Exacerbations in the UPLIFT Study.
Morjaria JB; Rigby A; Morice AH
Lung; 2017 Jun; 195(3):281-288. PubMed ID: 28255905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]